Hummingbird Resources Valuation
Is 2HM undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
4/6Valuation Score 4/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of 2HM when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: 2HM (€0.01) is trading below our estimate of fair value (€3.08)
Significantly Below Fair Value: 2HM is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 2HM?
Key metric: As 2HM is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.
| What is 2HM's PS Ratio? | |
|---|---|
| PS Ratio | 0.2x |
| Sales | US$129.05m |
| Market Cap | US$19.52m |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 2.6x |
| Enterprise Value/EBITDA | -163.8x |
| PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does 2HM's PS Ratio compare to its peers?
| Company | Forward PS | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 0.8x | ||
DLX Delignit | 0.3x | 10.3% | €24.2m |
IBU IBU-tec advanced materials | 0.7x | 19.2% | €34.2m |
BIG1 Bio-Gate | 0.9x | 16.3% | €6.5m |
BNN BRAIN Biotech | 1.2x | 8.5% | €68.8m |
2HM Hummingbird Resources | 0.2x | 75.7% | €15.4m |
Price-To-Sales vs Peers: 2HM is good value based on its Price-To-Sales Ratio (0.2x) compared to the peer average (0.8x).
Price to Sales Ratio vs Industry
How does 2HM's PS Ratio compare vs other companies in the European Metals and Mining Industry?
Price-To-Sales vs Industry: 2HM is good value based on its Price-To-Sales Ratio (0.2x) compared to the European Metals and Mining industry average (0.7x).
Price to Sales Ratio vs Fair Ratio
What is 2HM's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PS Ratio | 0.2x |
| Fair PS Ratio | n/a |
Price-To-Sales vs Fair Ratio: Insufficient data to calculate 2HM's Price-To-Sales Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.
Discover undervalued companies
Arkema
€5.8b
Manufactures and sells specialty chemicals and advanced materials worldwide.
V1S
€75.00
7D
-2.2%
1Y
-17.9%
Transcontinental
CA$1.4b
Engages in the flexible packaging business in Canada, the United States, Latin America, the United Kingdom, Australia, and New Zealand.
53L
CA$11.10
7D
-1.8%
1Y
53.1%
Trinseo
US$120.4m
Operates as a specialty material solutions provider in the United States, Europe, the Asia-Pacific, and internationally.
3XD
US$3.10
7D
-2.5%
1Y
-48.8%